Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments Wages, Salaries and Other

Ratios

Protara Therapeutics (TARA) Shares Issued (2016 - 2026)

Protara Therapeutics' Shares Issued history spans 8 years, with the latest figure at $1.9 million for Q1 2026.

Quarterly Shares Issued rose 194100.0% to $1.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Mar 2026, up 46.64% year-over-year, with the annual reading at $21000.0 for FY2025, 84.44% down from the prior year.
Shares Issued came in at $1.9 million for Q1 2026, up from $20000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $1.9 million in Q1 2026 to a low of $1000.0 in Q1 2025.